カテゴリー： LP Information, 世界, 部品/材料

世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場予測 2023年-2029年

◆英語タイトル：Global β-Nicotinamide Mononucleotide (NMN) Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU7775）◆商品コード：LP23JU7775
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：92
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場」は、過去の販売実績から2022年の世界のβ-ニコチンアミドモノヌクレオチド（NMN）の総販売量を検討し、2023年から2029年の予測されるβ-ニコチンアミドモノヌクレオチド（NMN）の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のβ-ニコチンアミドモノヌクレオチド（NMN）の市場規模を掲載し、XXX百万米ドル規模の世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場の詳細な分析を提供します。本インサイトレポートは、世界のβ-ニコチンアミドモノヌクレオチド（NMN）業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場における各社の独自のポジションをより深く理解するために、β-ニコチンアミドモノヌクレオチド（NMN）製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。β-ニコチンアミドモノヌクレオチド（NMN）の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。β-ニコチンアミドモノヌクレオチド（NMN）の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。β-ニコチンアミドモノヌクレオチド（NMN）のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

β-ニコチンアミドモノヌクレオチド（NMN）の世界主要メーカーとしては、GeneHarbor、 Herbalmax、 Genex Formulas、 Shinkowa Pharmaceutical、 Maac10 Formulas、 Bontac、 Shandong Sihuan Pharmaceutical、 EffePharm、 Zhejiang Jiahua Pharmchemicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のβ-ニコチンアミドモノヌクレオチド（NMN）市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではβ-ニコチンアミドモノヌクレオチド（NMN）市場をセグメンテーションし、種類別 (純度＜98%、純度≧98%)、用途別 (医療製品、化粧品、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度＜98%、純度≧98%

・用途別区分：医療製品、化粧品、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場の10年間の市場状況・展望は？
・世界および地域別に見たβ-ニコチンアミドモノヌクレオチド（NMN）市場成長の要因は何か？
・β-ニコチンアミドモノヌクレオチド（NMN）の市場機会はエンドマーケットの規模によってどのように変化するのか？
・β-ニコチンアミドモノヌクレオチド（NMN）のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：β-ニコチンアミドモノヌクレオチド（NMN）の年間販売量2018-2029、地域別現状・将来分析
・β-ニコチンアミドモノヌクレオチド（NMN）の種類別セグメント：純度＜98%、純度≧98%
・β-ニコチンアミドモノヌクレオチド（NMN）の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・β-ニコチンアミドモノヌクレオチド（NMN）の用途別セグメント：医療製品、化粧品、その他
・β-ニコチンアミドモノヌクレオチド（NMN）の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場
・企業別のグローバルβ-ニコチンアミドモノヌクレオチド（NMN）市場データ：2018-2023年の年間販売量、市場シェア
・企業別のβ-ニコチンアミドモノヌクレオチド（NMN）の年間売上：2018-2023年の売上、市場シェア
・企業別のβ-ニコチンアミドモノヌクレオチド（NMN）販売価格
・主要企業のβ-ニコチンアミドモノヌクレオチド（NMN）生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

β-ニコチンアミドモノヌクレオチド（NMN）の地域別レビュー
・地域別のβ-ニコチンアミドモノヌクレオチド（NMN）市場規模2018-2023：年間販売量、売上
・主要国別のβ-ニコチンアミドモノヌクレオチド（NMN）市場規模2018-2023：年間販売量、売上
・南北アメリカのβ-ニコチンアミドモノヌクレオチド（NMN）販売の成長
・アジア太平洋のβ-ニコチンアミドモノヌクレオチド（NMN）販売の成長
・ヨーロッパのβ-ニコチンアミドモノヌクレオチド（NMN）販売の成長
・中東・アフリカのβ-ニコチンアミドモノヌクレオチド（NMN）販売の成長

南北アメリカ市場
・南北アメリカの国別のβ-ニコチンアミドモノヌクレオチド（NMN）販売量、売上（2018-2023）
・南北アメリカのβ-ニコチンアミドモノヌクレオチド（NMN）の種類別販売量
・南北アメリカのβ-ニコチンアミドモノヌクレオチド（NMN）の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のβ-ニコチンアミドモノヌクレオチド（NMN）販売量、売上（2018-2023）
・アジア太平洋のβ-ニコチンアミドモノヌクレオチド（NMN）の種類別販売量
・アジア太平洋のβ-ニコチンアミドモノヌクレオチド（NMN）の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のβ-ニコチンアミドモノヌクレオチド（NMN）販売量、売上（2018-2023）
・ヨーロッパのβ-ニコチンアミドモノヌクレオチド（NMN）の種類別販売量
・ヨーロッパのβ-ニコチンアミドモノヌクレオチド（NMN）の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のβ-ニコチンアミドモノヌクレオチド（NMN）販売量、売上（2018-2023）
・中東・アフリカのβ-ニコチンアミドモノヌクレオチド（NMN）の種類別販売量
・中東・アフリカのβ-ニコチンアミドモノヌクレオチド（NMN）の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・β-ニコチンアミドモノヌクレオチド（NMN）の製造コスト構造分析
・β-ニコチンアミドモノヌクレオチド（NMN）の製造プロセス分析
・β-ニコチンアミドモノヌクレオチド（NMN）の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・β-ニコチンアミドモノヌクレオチド（NMN）の主要なグローバル販売業者
・β-ニコチンアミドモノヌクレオチド（NMN）の主要なグローバル顧客

地域別のβ-ニコチンアミドモノヌクレオチド（NMN）市場予測レビュー
・地域別のβ-ニコチンアミドモノヌクレオチド（NMN）市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・β-ニコチンアミドモノヌクレオチド（NMN）の種類別市場規模予測
・β-ニコチンアミドモノヌクレオチド（NMN）の用途別市場規模予測

主要企業分析
GeneHarbor、 Herbalmax、 Genex Formulas、 Shinkowa Pharmaceutical、 Maac10 Formulas、 Bontac、 Shandong Sihuan Pharmaceutical、 EffePharm、 Zhejiang Jiahua Pharmchemical
・企業情報
・β-ニコチンアミドモノヌクレオチド（NMN）製品
・β-ニコチンアミドモノヌクレオチド（NMN）販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
LPI (LP Information)’ newest research report, the “β-Nicotinamide Mononucleotide (NMN) Industry Forecast” looks at past sales and reviews total world β-Nicotinamide Mononucleotide (NMN) sales in 2022, providing a comprehensive analysis by region and market sector of projected β-Nicotinamide Mononucleotide (NMN) sales for 2023 through 2029. With β-Nicotinamide Mononucleotide (NMN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world β-Nicotinamide Mononucleotide (NMN) industry.
This Insight Report provides a comprehensive analysis of the global β-Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on β-Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global β-Nicotinamide Mononucleotide (NMN) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for β-Nicotinamide Mononucleotide (NMN) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global β-Nicotinamide Mononucleotide (NMN).
The global β-Nicotinamide Mononucleotide (NMN) market size is projected to grow from US$ 251.1 million in 2022 to US$ 320.1 million in 2029; it is expected to grow at a CAGR of 320.1 from 2023 to 2029.
Global key players of beta-nicotinamide mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, etc. Asia-Pacific is the largest producer of beta-nicotinamide mononucleotide (NMN), holds a share about 65%, followed by North America, and Europe . In terms of purity, content greater than or equal to 98% is the largest segment, with a share over 90%. And in terms of application, the largest segment is health care products, with a share over 90%.
This report presents a comprehensive overview, market shares, and growth opportunities of β-Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ＜98%
Purity ≥98%
Segmentation by application
Health Care Products
Cosmetics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
Bontac
Shandong Sihuan Pharmaceutical
EffePharm
Zhejiang Jiahua Pharmchemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global β-Nicotinamide Mononucleotide (NMN) market?
What factors are driving β-Nicotinamide Mononucleotide (NMN) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do β-Nicotinamide Mononucleotide (NMN) market opportunities vary by end market size?
How does β-Nicotinamide Mononucleotide (NMN) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global β-Nicotinamide Mononucleotide (NMN) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for β-Nicotinamide Mononucleotide (NMN) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for β-Nicotinamide Mononucleotide (NMN) by Country/Region, 2018, 2022 & 2029
2.2 β-Nicotinamide Mononucleotide (NMN) Segment by Type
2.2.1 Purity ＜98%
2.2.2 Purity ≥98%
2.3 β-Nicotinamide Mononucleotide (NMN) Sales by Type
2.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2018-2023)
2.3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2018-2023)
2.3.3 Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2018-2023)
2.4 β-Nicotinamide Mononucleotide (NMN) Segment by Application
2.4.1 Health Care Products
2.4.2 Cosmetics
2.4.3 Others
2.5 β-Nicotinamide Mononucleotide (NMN) Sales by Application
2.5.1 Global β-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2018-2023)
2.5.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2018-2023)
2.5.3 Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2018-2023)
3 Global β-Nicotinamide Mononucleotide (NMN) by Company
3.1 Global β-Nicotinamide Mononucleotide (NMN) Breakdown Data by Company
3.1.1 Global β-Nicotinamide Mononucleotide (NMN) Annual Sales by Company (2018-2023)
3.1.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2018-2023)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Annual Revenue by Company (2018-2023)
3.2.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (2018-2023)
3.2.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2018-2023)
3.3 Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Company
3.4 Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Product Location Distribution
3.4.2 Players β-Nicotinamide Mononucleotide (NMN) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for β-Nicotinamide Mononucleotide (NMN) by Geographic Region
4.1 World Historic β-Nicotinamide Mononucleotide (NMN) Market Size by Geographic Region (2018-2023)
4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic β-Nicotinamide Mononucleotide (NMN) Market Size by Country/Region (2018-2023)
4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Annual Sales by Country/Region (2018-2023)
4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Annual Revenue by Country/Region (2018-2023)
4.3 Americas β-Nicotinamide Mononucleotide (NMN) Sales Growth
4.4 APAC β-Nicotinamide Mononucleotide (NMN) Sales Growth
4.5 Europe β-Nicotinamide Mononucleotide (NMN) Sales Growth
4.6 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Growth
5 Americas
5.1 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Country
5.1.1 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Country (2018-2023)
5.1.2 Americas β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2018-2023)
5.2 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Type
5.3 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Region
6.1.1 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Region (2018-2023)
6.1.2 APAC β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2018-2023)
6.2 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Type
6.3 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe β-Nicotinamide Mononucleotide (NMN) by Country
7.1.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2018-2023)
7.1.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2018-2023)
7.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type
7.3 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) by Country
8.1.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2018-2023)
8.1.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2018-2023)
8.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Type
8.3 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of β-Nicotinamide Mononucleotide (NMN)
10.3 Manufacturing Process Analysis of β-Nicotinamide Mononucleotide (NMN)
10.4 Industry Chain Structure of β-Nicotinamide Mononucleotide (NMN)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 β-Nicotinamide Mononucleotide (NMN) Distributors
11.3 β-Nicotinamide Mononucleotide (NMN) Customer
12 World Forecast Review for β-Nicotinamide Mononucleotide (NMN) by Geographic Region
12.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
12.1.1 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Region (2024-2029)
12.1.2 Global β-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Type
12.7 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Application
13 Key Players Analysis
13.1 GeneHarbor
13.1.1 GeneHarbor Company Information
13.1.2 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GeneHarbor Main Business Overview
13.1.5 GeneHarbor Latest Developments
13.2 Herbalmax
13.2.1 Herbalmax Company Information
13.2.2 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Herbalmax Main Business Overview
13.2.5 Herbalmax Latest Developments
13.3 Genex Formulas
13.3.1 Genex Formulas Company Information
13.3.2 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Genex Formulas Main Business Overview
13.3.5 Genex Formulas Latest Developments
13.4 Shinkowa Pharmaceutical
13.4.1 Shinkowa Pharmaceutical Company Information
13.4.2 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Shinkowa Pharmaceutical Main Business Overview
13.4.5 Shinkowa Pharmaceutical Latest Developments
13.5 Maac10 Formulas
13.5.1 Maac10 Formulas Company Information
13.5.2 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Maac10 Formulas Main Business Overview
13.5.5 Maac10 Formulas Latest Developments
13.6 Bontac
13.6.1 Bontac Company Information
13.6.2 Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.6.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bontac Main Business Overview
13.6.5 Bontac Latest Developments
13.7 Shandong Sihuan Pharmaceutical
13.7.1 Shandong Sihuan Pharmaceutical Company Information
13.7.2 Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.7.3 Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shandong Sihuan Pharmaceutical Main Business Overview
13.7.5 Shandong Sihuan Pharmaceutical Latest Developments
13.8 EffePharm
13.8.1 EffePharm Company Information
13.8.2 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.8.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 EffePharm Main Business Overview
13.8.5 EffePharm Latest Developments
13.9 Zhejiang Jiahua Pharmchemical
13.9.1 Zhejiang Jiahua Pharmchemical Company Information
13.9.2 Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.9.3 Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Zhejiang Jiahua Pharmchemical Main Business Overview
13.9.5 Zhejiang Jiahua Pharmchemical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. β-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. β-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ＜98%
Table 4. Major Players of Purity ≥98%
Table 5. Global β-Nicotinamide Mononucleotide (NMN) Sales by Type (2018-2023) & (Kg)
Table 6. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2018-2023)
Table 7. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2018-2023) & ($ million)
Table 8. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2018-2023)
Table 9. Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2018-2023) & (Kg)
Table 11. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2018-2023)
Table 12. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2018-2023)
Table 13. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2018-2023)
Table 14. Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global β-Nicotinamide Mononucleotide (NMN) Sales by Company (2018-2023) & (Kg)
Table 16. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2018-2023)
Table 17. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2018-2023)
Table 19. Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area
Table 21. Players β-Nicotinamide Mononucleotide (NMN) Products Offered
Table 22. β-Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global β-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share Geographic Region (2018-2023)
Table 27. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global β-Nicotinamide Mononucleotide (NMN) Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2018-2023)
Table 31. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas β-Nicotinamide Mononucleotide (NMN) Sales by Country (2018-2023) & (Kg)
Table 34. Americas β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2018-2023)
Table 35. Americas β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2018-2023)
Table 37. Americas β-Nicotinamide Mononucleotide (NMN) Sales by Type (2018-2023) & (Kg)
Table 38. Americas β-Nicotinamide Mononucleotide (NMN) Sales by Application (2018-2023) & (Kg)
Table 39. APAC β-Nicotinamide Mononucleotide (NMN) Sales by Region (2018-2023) & (Kg)
Table 40. APAC β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2018-2023)
Table 41. APAC β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2018-2023)
Table 43. APAC β-Nicotinamide Mononucleotide (NMN) Sales by Type (2018-2023) & (Kg)
Table 44. APAC β-Nicotinamide Mononucleotide (NMN) Sales by Application (2018-2023) & (Kg)
Table 45. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2018-2023) & (Kg)
Table 46. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2018-2023)
Table 47. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2018-2023)
Table 49. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type (2018-2023) & (Kg)
Table 50. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of β-Nicotinamide Mononucleotide (NMN)
Table 58. Key Market Challenges & Risks of β-Nicotinamide Mononucleotide (NMN)
Table 59. Key Industry Trends of β-Nicotinamide Mononucleotide (NMN)
Table 60. β-Nicotinamide Mononucleotide (NMN) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. β-Nicotinamide Mononucleotide (NMN) Distributors List
Table 63. β-Nicotinamide Mononucleotide (NMN) Customer List
Table 64. Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GeneHarbor Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 79. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 80. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. GeneHarbor Main Business
Table 82. GeneHarbor Latest Developments
Table 83. Herbalmax Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 84. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 85. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Herbalmax Main Business
Table 87. Herbalmax Latest Developments
Table 88. Genex Formulas Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 89. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 90. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Genex Formulas Main Business
Table 92. Genex Formulas Latest Developments
Table 93. Shinkowa Pharmaceutical Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 94. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 95. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Shinkowa Pharmaceutical Main Business
Table 97. Shinkowa Pharmaceutical Latest Developments
Table 98. Maac10 Formulas Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 99. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 100. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Maac10 Formulas Main Business
Table 102. Maac10 Formulas Latest Developments
Table 103. Bontac Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 104. Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 105. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Bontac Main Business
Table 107. Bontac Latest Developments
Table 108. Shandong Sihuan Pharmaceutical Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 109. Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 110. Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Shandong Sihuan Pharmaceutical Main Business
Table 112. Shandong Sihuan Pharmaceutical Latest Developments
Table 113. EffePharm Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 114. EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 115. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. EffePharm Main Business
Table 117. EffePharm Latest Developments
Table 118. Zhejiang Jiahua Pharmchemical Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 119. Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 120. Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Zhejiang Jiahua Pharmchemical Main Business
Table 122. Zhejiang Jiahua Pharmchemical Latest Developments
List of Figures
Figure 1. Picture of β-Nicotinamide Mononucleotide (NMN)
Figure 2. β-Nicotinamide Mononucleotide (NMN) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global β-Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. β-Nicotinamide Mononucleotide (NMN) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ＜98%
Figure 10. Product Picture of Purity ≥98%
Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2022
Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2018-2023)
Figure 13. β-Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products
Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2018-2023) & (Kg)
Figure 15. β-Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics
Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2018-2023) & (Kg)
Figure 17. β-Nicotinamide Mononucleotide (NMN) Consumed in Others
Figure 18. Global β-Nicotinamide Mononucleotide (NMN) Market: Others (2018-2023) & (Kg)
Figure 19. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2022)
Figure 20. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2022
Figure 21. β-Nicotinamide Mononucleotide (NMN) Sales Market by Company in 2022 (Kg)
Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company in 2022
Figure 23. β-Nicotinamide Mononucleotide (NMN) Revenue Market by Company in 2022 ($ Million)
Figure 24. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2022
Figure 25. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region in 2022
Figure 27. Americas β-Nicotinamide Mononucleotide (NMN) Sales 2018-2023 (Kg)
Figure 28. Americas β-Nicotinamide Mononucleotide (NMN) Revenue 2018-2023 ($ Millions)
Figure 29. APAC β-Nicotinamide Mononucleotide (NMN) Sales 2018-2023 (Kg)
Figure 30. APAC β-Nicotinamide Mononucleotide (NMN) Revenue 2018-2023 ($ Millions)
Figure 31. Europe β-Nicotinamide Mononucleotide (NMN) Sales 2018-2023 (Kg)
Figure 32. Europe β-Nicotinamide Mononucleotide (NMN) Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales 2018-2023 (Kg)
Figure 34. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue 2018-2023 ($ Millions)
Figure 35. Americas β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2022
Figure 36. Americas β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country in 2022
Figure 37. Americas β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2018-2023)
Figure 38. Americas β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2018-2023)
Figure 39. United States β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2022
Figure 44. APAC β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Regions in 2022
Figure 45. APAC β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2018-2023)
Figure 46. APAC β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2018-2023)
Figure 47. China β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 51. India β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2022
Figure 55. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country in 2022
Figure 56. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2018-2023)
Figure 57. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2018-2023)
Figure 58. Germany β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 59. France β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2022
Figure 64. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2018-2023)
Figure 67. Egypt β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of β-Nicotinamide Mononucleotide (NMN) in 2022
Figure 73. Manufacturing Process Analysis of β-Nicotinamide Mononucleotide (NMN)
Figure 74. Industry Chain Structure of β-Nicotinamide Mononucleotide (NMN)
Figure 75. Channels of Distribution
Figure 76. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Forecast by Region (2024-2029)
Figure 77. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場予測 2023年-2029年(Global β-Nicotinamide Mononucleotide (NMN) Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のニコチンアミドモノヌクレオチド（NMN）市場2023年：企業・地域・タイプ・用途別分析
  • 世界のベータニコチンアミドモノヌクレオチド（NMN）市場2023年：企業・地域・タイプ・用途別分析
  • 化粧品用ニコチンアミドモノヌクレオチドのグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆